October 16, 2025 – International law firm McDermott Will & Schulte has been recognized as a leading firm in Chambers UK 2026, highlighting the London office’s deep technical knowledge, strategic acumen, and creative problem-solving capabilities across multiple practice areas; as well as the firm’s strong growth trajectory in the United Kingdom market.

McDermott earned nine practice rankings, including five new and one improved ranking. The firm upheld Band 1 rankings in Healthcare: Private Sector and Investment Funds: Hedge Funds and received an improved ranking in Leveraged Finance: Lenders: Mid-Market (Band 2). The firm also received more than 20 individual lawyer rankings, with three new and four improved rankings.

The firm achieved new rankings in:

• Shareholder Activism: Activist Representation (Band 2)
• Leveraged Finance: Borrowers/Sponsors: Mid-Market (Band 3)
• Private Equity: Buyouts: Up to £500 million (Band 4)
• Investment Funds: Private Equity (Band 5)
• Restructuring/Insolvency (Band 5)

The firm’s overall rankings have been bolstered following the 2025 merger of McDermott Will & Emery with Schulte Roth & Zabel, strengthening the London office and creating a powerful presence that delivers results. The expanded team now offers clients unmatched cross-border capabilities, driving growth and innovation in a competitive legal market.

Market commentators state that the firm is “responsive, thoughtful and commercial…[and] committed to putting clients first, which comes through in every aspect of their work.” A client notes that “the team’s problem-solving mindset and client-first culture are differentiators that the team has been demonstrating consistently.” McDermott is also described as “well connected and able to provide valuable additional market insight. It offers creative thinking to progress legal challenges, together with solid advice on the options.”

View the full Chambers UK rankings list.

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.

October 15, 2025 — International law firm McDermott Will & Schulte has been named to Turnarounds & Workouts’ European Restructuring Practices of Major US Law Firms list for the third consecutive year.

The 2025 special report recognized McDermott’s European business restructuring group leads: Aymen Mahmoud, Mark Fennessy, Timothée Gagnepain, Dr. Uwe Goetker, and Dr. Matthias Kampshoff.

McDermott Will & Schulte’s business restructuring group is a global team knowledgeable in all aspects of distressed transactions. The team has experience—and a veritable track record—advising the full range of interested parties, domestically and internationally, from the debtors requiring relief to the interested stakeholders lining up to recoup their positions.

Learn more about our capabilities.

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.

October 15, 2025 – McDermott Will & Schulte’s health & life sciences group are once again recognized in LMG Life Sciences, receiving USA nationwide rankings across seven categories. This achievement reflects the firm’s continued reputation as a premier destination for clients navigating high-stakes issues at the intersection of law, science, and business.

The team continues to be acknowledged for its depth of experience and strategic legal counsel. Known for guiding clients through complex patent litigation and intellectual property strategy, the group also excels in FDA regulatory matters, product liability disputes, and sensitive government and white-collar investigations. The firm’s work in antitrust, healthcare pricing and reimbursement, and patent prosecution further highlights the breadth and strength of the practice.

USA Nationwide rankings include:

• White-Collar/Government Investigations – Tier 2
• Antitrust – Tier 3
• FDA: Medical Device – Tier 3
• General Patent Litigation – Tier 3
• Healthcare Pricing & Reimbursement – Tier 3
• Patent Strategy & Management – Tier 3
• Patent Prosecution – Tier 3

In addition to the practice-wide accolades, LMG Life Sciences recognized 14 lawyers for their outstanding contributions.

LMG Life Sciences is the only legal directory dedicated entirely to the life sciences industry. Its annual rankings highlight leading firms and individual lawyers across key practice areas, drawing on in-depth submissions, client and peer feedback, and independent market research.

View the full list of rankings here.

Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.